Literature DB >> 9657785

Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study.

W J Meerding1, L Bonneux, J J Polder, M A Koopmanschap, P J van der Maas.   

Abstract

OBJECTIVES: To determine the demands on healthcare resources caused by different types of illnesses and variation with age and sex.
DESIGN: Information on healthcare use was obtained from all 22 healthcare sectors in the Netherlands. Most important sectors (hospitals, nursing homes, inpatient psychiatric care, institutions for mentally disabled people) have national registries. Total expenditures for each sector were subdivided into 21 age groups, sex, and 34 diagnostic groups.
SETTING: Netherlands, 1994. MAIN OUTCOME MEASURES: Proportion of healthcare budget spent on each category of disease and cost of health care per person at various ages.
RESULTS: After the first year of life, costs per person for children were lowest. Costs rose slowly throughout adult life and increased exponentially from age 50 onwards till the oldest age group (> or = 95). The top five areas of healthcare costs were mental retardation, musculoskeletal disease (predominantly joint disease and dorsopathy), dementia, a heterogeneous group of other mental disorders, and ill defined conditions. Stroke, all cancers combined, and coronary heart disease ranked 7, 8, and 10, respectively.
CONCLUSIONS: The main determinants of healthcare use in the Netherlands are old age and disabling conditions, particularly mental disability. A large share of the healthcare budget is spent on long term nursing care, and this cost will inevitably increase further in an ageing population. Non-specific cost containment measures may endanger the quality of care for old and mentally disabled people.

Entities:  

Mesh:

Year:  1998        PMID: 9657785      PMCID: PMC28601          DOI: 10.1136/bmj.317.7151.111

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  3 in total

1.  Rationing health care: the choice before us.

Authors:  H Aaron; W B Schwartz
Journal:  Science       Date:  1990-01-26       Impact factor: 47.728

2.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-17       Impact factor: 79.321

3.  Longevity and Medicare expenditures.

Authors:  J Lubitz; J Beebe; C Baker
Journal:  N Engl J Med       Date:  1995-04-13       Impact factor: 91.245

  3 in total
  59 in total

1.  The discount rate in the economic evaluation of prevention: a thought experiment.

Authors:  L Bonneux; E Birnie
Journal:  J Epidemiol Community Health       Date:  2001-02       Impact factor: 3.710

2.  The expiry date of man: a synthesis of evolutionary biology and public health.

Authors:  L Bonneux; J J Barendregt; P J Van der Maas
Journal:  J Epidemiol Community Health       Date:  1998-10       Impact factor: 3.710

3.  Patients with learning disability in the community.

Authors:  T J Aspray; R M Francis; S P Tyrer; S J Quilliam
Journal:  BMJ       Date:  1999-02-20

Review 4.  The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.

Authors:  C Sarti; M Kaarisalo; J Tuomilehto
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

5.  Standardizing the inclusion of indirect medical costs in economic evaluations.

Authors:  Pieter H M van Baal; Albert Wong; Laurentius C J Slobbe; Johan J Polder; Werner B F Brouwer; G Ardine de Wit
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

Review 6.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Elvis to Eminem: quantifying the price of fame through early mortality of European and North American rock and pop stars.

Authors:  Mark A Bellis; Tom Hennell; Clare Lushey; Karen Hughes; Karen Tocque; John R Ashton
Journal:  J Epidemiol Community Health       Date:  2007-10       Impact factor: 3.710

8.  Use of national health interview data to measure the burden of disease and injuries.

Authors:  F J Basterra-Gortari; M Segui-Gomez
Journal:  Inj Prev       Date:  2007-08       Impact factor: 2.399

9.  Variations in Lifetime Healthcare Costs across a Population.

Authors:  Evelyn L Forget; Leslie L Roos; Raisa B Deber; Randy Walld
Journal:  Healthc Policy       Date:  2008-08

10.  Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.

Authors:  David R Rappange; Werner B F Brouwer; Rudolf T Hoogenveen; Pieter H M Van Baal
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.